Adrian Adams, Chief Executive Officer at Aralez Pharmaceuticals Inc. (ARLZ), bought 500,000 shares at $2.46 ($1.2M) on 2017-03-15, disclosed to the SEC on 2017-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AKBA | BUY | 2019-11-21 | $171K | — | Filing → |
| POZN | BUY | 2015-11-12 | $6.6M | — | Filing → |
| AUXL | SELL | 2014-12-08 | $1.4M | — | Filing → |